Avantor, Inc. (AVTR)
14.81
-0.07
(-0.47%)
USD |
NYSE |
Sep 11, 16:00
14.80
0.00 (0.00%)
Pre-Market: 20:00
Avantor Price to Book Value : 1.780 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.780 |
| September 10, 2026 | 1.788 |
| September 09, 2026 | 1.788 |
| September 08, 2026 | 1.832 |
| September 04, 2026 | 1.799 |
| September 03, 2026 | 1.825 |
| September 02, 2026 | 1.760 |
| September 01, 2026 | 1.706 |
| August 31, 2026 | 1.747 |
| August 28, 2026 | 1.752 |
| August 27, 2026 | 1.756 |
| August 26, 2026 | 1.742 |
| August 25, 2026 | 1.733 |
| August 24, 2026 | 1.713 |
| August 21, 2026 | 1.738 |
| August 20, 2026 | 1.712 |
| August 19, 2026 | 1.677 |
| August 18, 2026 | 1.602 |
| August 17, 2026 | 1.622 |
| August 14, 2026 | 1.641 |
| August 13, 2026 | 1.664 |
| August 12, 2026 | 1.674 |
| August 11, 2026 | 1.654 |
| August 10, 2026 | 1.650 |
| August 07, 2026 | 1.633 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.584 |
| August 05, 2026 | 1.605 |
| August 04, 2026 | 1.644 |
| August 03, 2026 | 1.642 |
| July 31, 2026 | 1.656 |
| July 30, 2026 | 1.665 |
| July 29, 2026 | 1.728 |
| July 28, 2026 | 1.492 |
| July 27, 2026 | 1.413 |
| July 24, 2026 | 1.375 |
| July 23, 2026 | 1.364 |
| July 22, 2026 | 1.316 |
| July 21, 2026 | 1.320 |
| July 20, 2026 | 1.281 |
| July 17, 2026 | 1.330 |
| July 16, 2026 | 1.353 |
| July 15, 2026 | 1.346 |
| July 14, 2026 | 1.357 |
| July 13, 2026 | 1.269 |
| July 10, 2026 | 1.248 |
| July 09, 2026 | 1.263 |
| July 08, 2026 | 1.173 |
| July 07, 2026 | 1.226 |
| July 06, 2026 | 1.246 |
| July 02, 2026 | 1.24 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Medpace Holdings, Inc. | 37.70 |
| Champions Oncology, Inc. | 18.23 |
| Personalis, Inc. | 7.332 |
| Adaptive Biotechnologies Corp. | 26.93 |
| 10X Genomics, Inc. | 10.82 |
Price to Book Value Related Metrics
| PS Ratio | 1.532 |
| Price to Free Cash Flow | 22.11 |
| Price | 14.81 |
| Earnings Yield | -5.72% |
| Market Cap | 10.02B |
| Operating PE Ratio | 18.68 |
| Normalized PE Ratio | 1763.10 |